Who Exports Potassium from India — 877 Suppliers Behind a $642.2M Market
India's potassium export market is supplied by 877 active exporters who collectively shipped $642.2M across 15,000 shipments. AUROBINDO PHARMA LTD leads with a 14.0% market share, followed by MYLAN LABORATORIES LIMITED and ZYDUS LIFESCIENCES LIMITED. The top 5 suppliers together control 48.4% of total export value, reflecting a moderately competitive market structure.
Top Potassium Exporters from India — Ranked by Export Value
AUROBINDO PHARMA LTD is the leading potassium exporter from India, holding a 14.0% share of the $642.2M market across 15,000 shipments from 877 exporters. The top 5 suppliers — AUROBINDO PHARMA LTD, MYLAN LABORATORIES LIMITED, ZYDUS LIFESCIENCES LIMITED, RUBICON RESEARCH PRIVATE LIMITED, AUROBINDO PHARMA LIMITED — collectively control 48.4% of total export value, indicating a competitive market. Individual shares are: AUROBINDO PHARMA LTD (14.0%), MYLAN LABORATORIES LIMITED (12.3%), ZYDUS LIFESCIENCES LIMITED (9.4%), RUBICON RESEARCH PRIVATE LIMITED (7.3%), AUROBINDO PHARMA LIMITED (5.5%).
Top Potassium Exporters from India
Ranked by export value · 877 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | AUROBINDO PHARMA LTD POTASSIUM CL TAB PR 600MG 90BT HK MY TENPACKS 73635AMOXICILLIN AND CLAVULANATE POTASSIUM FOAZILSARTAN MEDOXOMIL POTASSIUM | $89.6M | 40 | 14.0% |
| 2 | MYLAN LABORATORIES LIMITED POTASSIUM CL TAB PR 600MG 90BT HK MY TENPACKS 73635POTASSIUM CHLORIDE EXTENDED RELEASE TABPOTASSIUM CL TAB PR 600MG 90BT HK MY TEN | $78.8M | 3 | 12.3% |
| 3 | ZYDUS LIFESCIENCES LIMITED AZILSARTAN MEDOXOMIL POTASSIUMZAART 50 TABLETS .AZILSARTAN MEDOXOMIL POTASSIUM TAK-491 | $60.2M | 12 | 9.4% |
| 4 | RUBICON RESEARCH PRIVATE LIMITED | $47.1M | 1 | 7.3% |
| 5 | AUROBINDO PHARMA LIMITED POTASSIUM CL TAB PR 600MG 90BT HK MY TENPACKS 73635AMOXICILLIN AND CLAVULANATE POTASSIUM FOAZILSARTAN MEDOXOMIL POTASSIUM | $35.1M | 29 | 5.5% |
| 6 | GRANULES INDIA LIMITED | $25.6M | 3 | 4.0% |
| 7 | MICRO LABS LIMITED AZILSARTAN MEDOXOMIL POTASSIUMZAART 50 TABLETS .COMBIPACK OF AMOXICILLIN AND POTASSIUM C | $25.1M | 38 | 3.9% |
| 8 | MEDREICH LIMITED POTASSIUM CL TAB PR 600MG 90BT HK MY TENPACKS 73635COMBIPACK OF AMOXICILLIN AND POTASSIUM CPHARMACEUTICAL PRODUCTS HARMLESS MEDICINE-SAPHLOR-50 | $20.9M | 24 | 3.3% |
| 9 | CAPLIN POINT LABORATORIES LIMITED LOSARTAN POTASSIUM TABLETS USP 50MGDICLOFENAC POTASSIUM TABLETS USP 50MGLOSARTAN POTASSIUM TABLETS USP 50 MG | $16.6M | 10 | 2.6% |
| 10 | ZYDUS TAKEDA HEALTHCARE PRIVATE LIMITED AZILSARTAN MEDOXOMIL POTASSIUMZAART 50 TABLETS .AZILSARTAN MEDOXOMIL POTASSIUM TAK-491 | $14.2M | 1 | 2.2% |
| 11 | CIPLA LIMITED ZAART 50 TABLETS .ZAART 50 TABLETS LOSARTAN POTASSIUM 50LOSACAR 50 MG TAB 15X7 TABLOSARTAN POTASSIUM15X7 | $14.1M | 10 | 2.2% |
| 12 | APL HEALTHCARE LIMITED COMBIPACK OF AMOXICILLIN AND POTASSIUM CAMOXICILLIN AND POTASSIUM CLAVULANATEAMOXICILLIN AND POTASSIUM CLAVULANATE F | $10.2M | 1 | 1.6% |
| 13 | MEDOPHARM AMOXICILLIN AND CLAVULANATE POTASSIUM FOAZILSARTAN MEDOXOMIL POTASSIUMAZILSARTAN MEDOXOMIL POTASSIUM TAK-491 | $9.8M | 14 | 1.5% |
| 14 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $9.7M | 1 | 1.5% |
| 15 | IPCA LABORATORIES LIMITED POTASSIUM CL TAB PR 600MG 90BT HK MY TENPACKS 73635ZAART 50 TABLETS .PHARMACEUTICAL PRODUCTS HARMLESS MEDICINE-SAPHLOR-50 | $6.8M | 15 | 1.1% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Potassium exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| Aurobindo Pharma Limited | Warning Letter (January 2 | Yes (Date not specif | Yes | Multiple | Received FDA warning letter for CGMP deviations; holds WHO and EU GMP certificat |
| Mylan Laboratories Limited | Warning Letter (August 20 | Yes (Date not specif | Yes | Multiple | Received FDA warning letter for CGMP deviations; holds WHO and EU GMP certificat |
| Zydus Lifesciences Limited | Approved | Yes (Date not specif | Yes | Multiple | Holds FDA approvals and WHO/EU GMP certifications; no FDA warning letters. |
| Granules India Limited | Approved | Yes (Date not specif | Yes | Multiple | Holds FDA approvals and WHO/EU GMP certifications; no FDA warning letters. |
| Micro Labs Limited | Approved | Yes (Date not specif | Yes | Multiple | Holds FDA approvals and WHO/EU GMP certifications; no FDA warning letters. |
| Medreich Limited | Approved | Yes (Date not specif | Yes | Multiple | Holds FDA approvals and WHO/EU GMP certifications; no FDA warning letters. |
| Caplin Point Laboratories Limited | Approved | Yes (Date not specif | Yes | Multiple | Holds FDA approvals and WHO/EU GMP certifications; no FDA warning letters. |
| Cipla Limited | Approved | Yes (Date not specif | Yes | Multiple | Holds FDA approvals and WHO/EU GMP certifications; no FDA warning letters. |
| Ipca Laboratories Limited | Warning Letter (January 2 | Yes (Date not specif | Yes | Multiple | Received FDA warning letter for CGMP deviations; holds WHO and EU GMP certificat |
TransData Nexus reviewed the regulatory standing of 9 leading Potassium exporters from India. 6 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. 3 suppliers have received FDA regulatory actions — buyers should verify current remediation status before placing orders. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Potassium sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as India's "Bulk Drug Capital," is a pivotal hub for the production of active pharmaceutical ingredients (APIs) and bulk drugs. The city's pharmaceutical landscape is anchored by Genome Valley, a dedicated biotech park that fosters research and development in pharmaceuticals and biotechnology. Hyderabad Pharma City, an emerging integrated cluster, aims to consolidate API and formulation manufacturing with shared utilities and environmental management systems. This robust infrastructure supports major exporters like Aurobindo Pharma Ltd., which leads in potassium-based pharmaceutical exports with $89.6 million, accounting for 14.0% of the total exports in this category.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region hosts a concentration of manufacturing units specializing in the production of finished dosage forms, including tablets, capsules, and injectables. Companies such as Zydus Lifesciences Limited, contributing $60.2 million (9.4%) to potassium-based pharmaceutical exports, and Mylan Laboratories Limited, with $78.8 million (12.3%), have established significant operations here. The presence of advanced manufacturing facilities and a skilled workforce makes this cluster a critical player in the formulation segment of the pharmaceutical industry.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a strategic export gateway for India's pharmaceutical products. Proximity to major ports like Nhava Sheva (Jawaharlal Nehru Port) facilitates efficient international shipping, making it an ideal location for companies targeting global markets. This region supports a diverse range of pharmaceutical activities, from manufacturing to logistics, enhancing the export capabilities of firms operating within this cluster.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing hub, partly due to favorable tax incentives offered in the past. The region hosts numerous formulation units, contributing to the production of a wide array of pharmaceutical products. While the initial tax benefits have phased out, the established infrastructure and ecosystem continue to attract pharmaceutical companies.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Logistics Infrastructure: Prioritize suppliers with proximity to major ports and robust logistics networks to ensure timely and cost-effective exports.
- Assess Regulatory Compliance: Ensure that suppliers adhere to international quality standards and regulatory requirements to maintain product integrity and market access.
- Monitor Market Concentration: Given that the top five exporters account for 48.4% of potassium-based pharmaceutical exports, consider partnerships with both leading and emerging companies to balance market exposure.
By strategically analyzing and engaging with India's pharmaceutical clusters, companies can optimize their sourcing strategies for potassium-based pharmaceuticals, leveraging regional strengths and mitigating potential risks.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Potassium exporters from India
Aurobindo Pharma Limited — Aurobindo Pharma acquires remaining 49% stake in GLS Pharma
In August 2025, Aurobindo Pharma Limited completed the acquisition of the remaining 49% stake in GLS Pharma, thereby gaining full ownership of the Hyderabad-based oncology company. - IMPACT: This acquisition is expected to enhance Aurobindo's oncology product portfolio, potentially increasing potassium-based product exports.
Impact: This acquisition is expected to enhance Aurobindo's oncology product portfolio, potentially increasing potassium-based product exports.
Rubicon Research Private Limited — Rubicon Research acquires Meditab Specialities' Satara facility
In July 2021, Rubicon Research Private Limited acquired Meditab Specialities Limited's oral liquid dosage and nasal product manufacturing facility located in Satara, Maharashtra. - IMPACT: The acquisition is anticipated to expand Rubicon's manufacturing capabilities, potentially boosting potassium-based product exports.
Impact: The acquisition is anticipated to expand Rubicon's manufacturing capabilities, potentially boosting potassium-based product exports.
Zydus Lifesciences Limited — Cadila Healthcare rebrands as Zydus Lifesciences Limited
In February 2022, Cadila Healthcare Limited announced its rebranding to Zydus Lifesciences Limited to reflect its expanded focus beyond pharmaceuticals. - IMPACT: The rebranding may influence the company's strategic direction, potentially affecting potassium-based product exports.
Impact: The rebranding may influence the company's strategic direction, potentially affecting potassium-based product exports.
Common Questions — Potassium Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which potassium supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, AUROBINDO PHARMA LTD leads with 1,345 recorded shipments worth $89.6M. MYLAN LABORATORIES LIMITED (91 shipments) and ZYDUS LIFESCIENCES LIMITED (262 shipments) are also established high-volume exporters.
Q How many potassium manufacturers are there in India?
India has 877 active potassium exporters with a combined export market of $642.2M across 15,000 shipments to 177 countries. The top 5 suppliers hold 48.4% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for potassium from India?
Average FOB unit price: $13.76 per unit, ranging from $0.00 to $8899.88. Average shipment value: $42.8K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 877 verified Indian exporters of Potassium ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 15,000 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 177 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
15,000 Verified Shipments
877 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists